Executive Order 14420: Delivering Gold Standard Childhood Vaccine Recommendations for Americans
President: Donald J. Trump
Required HHS, CDC and ACIP to use specified evidence, transparency, conflict-of-interest and communication practices when developing federal childhood-vaccine recommendations.
Status: In effect.
Is Executive Order 14420 still in effect? Yes. Active; evidence, transparency and recommendation procedures directed.
What does Executive Order 14420 do?
The text directs HHS and CDC to apply specified evidence and transparency standards, and ACIP to conduct public recommendation process.
Reading the operative provisions of Executive Order 14420
EO 14420 directs HHS, CDC and ACIP to use specified evidence, transparency, conflict-of-interest and communication practices when developing federal childhood-vaccine recommendations. It follows EO 14407’s review of peer-country schedules. The Federal Register text of EO 14420 sets process requirements; it does not itself approve a vaccine or change the schedule for children.
ACIP recommendations involve evidence review, public meetings and votes, followed by CDC adoption and communication. The order directs agencies to evaluate relevant evidence and disclose conflicts, but the quality of a recommendation still depends on the methods, data and transparent explanation. A recommendation for routine use, an FDA product label and a state school requirement are separate decisions with distinct legal effects.
Parents should consult current CDC recommendations and health professionals for individual medical questions. The order does not override medical contraindications or establish a single rule for every child. To assess implementation, examine ACIP agendas and evidence reviews, CDC adoption notices, conflict disclosures and public communications. The follow-up builds on EO 14407 while leaving the formal recommendation and adoption process in place.
The order also requires agencies to communicate uncertainty and conflicts clearly, so families can see what evidence informed a recommendation and whether committee members disclosed relevant interests. Transparency does not mean that recommendations can be made without scientific review or that every public comment changes the outcome. ACIP’s records, evidence tables and CDC adoption notices provide the audit trail for a specific recommendation.
Before and after
Before the order
ACIP recommendations followed statutory advisory procedures, evidence frameworks, public meetings and CDC adoption, while FDA separately licensed products.
After the order
HHS, CDC and ACIP were directed to incorporate the order’s evidence and transparency requirements into recommendation work.
At this September 15 review, the order was only weeks old. CDC’s ACIP process remained the identifiable implementation channel; no amendment, revocation, final order-wide implementation report or material order-specific injunction was found in the official sources searched.
Who had to do what
| Agency / office | Action | Timing / position |
|---|---|---|
| HHS and CDC | Apply specified evidence and transparency standards | Ongoing |
| ACIP | Conduct public recommendation process | Meeting-specific |
| HHS | Publish rationale and implementation materials | After decisions |
What happened next
EO 14420 signed.
Legal and source detail
How it works legally
A recommendation, an FDA product license, federal program coverage and a state vaccination requirement are legally distinct. EO 14420 can direct executive procedures but cannot substitute presidential findings for FDA statutory decisions, override Federal Advisory Committee Act duties or command state legislation.
Sources by type
If a source is unavailable, first check the cited publisher or another official repository. The cited publisher remains the authority.
Primary and official sources
Orders, laws, court records and official implementation material.
How we checked this
Last checked against the sources above on September 15, 2026. How we research →